Drugs & Arrhythmia (Lever) Flashcards

1
Q

What are some causes of Bradycardias

A
  • Physiological mediated
  • Atrioventricular node and sinus node conduction disorders
  • Neural mediated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some causes of Tachycardias

A

Automaticity/triggered activity. Re-entrant mechanisms.

  • Atrial
  • Junctional (supraventricular tachycardia (SVT)
  • Ventricular (scar, ‘normal’ hearts)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the different types of Cardiac Devices for arrythmias?

What are the different functions of Cardiac Devices?

A

Different types include:

  • Single chamber AAI (atrial) or VVI (ventricular) (R)
    • First letter- chamber the pacemaker is placed, and the 2nd is the chamber you are listening to, and the 3rd- what it does
      • T= triggered
      • I= Inhibited
  • Dual chamber DDD (both atrial and ventricular) (R)
  • Pacemaker vs ICD (implantable cardioverter defibrillator)
    • Pacemakers treat slow heartbeats (anti-bradycardic)
    • Defibrillator control fast heartbeats (anti-tachycardic)

Functions include:

  • Rate support
  • Atrioventricular (AV) synchrony
  • Ventriculoventricular (VV) synchrony via CRT (cardiac resynchronization therapy) device

Other devices include vasovagal syncope devices, monitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the indicators for Device Support?

A
  • Pacemaker used in
    • high grade AV block,
    • symptomatic sinus node disease
  • Defibrillator used in
    • aborted SCD (sudden cardiac death)/ sustained VT in structural heart disease
    • High risk of SCD *
  • CRT used in (Cardiac Resynchronization Therapy)
    • cardiomyopathy
    • LBBB (left bundle branch block)

Use of these devices are also accompanied by some risks (venous stenosis, valve infections, pneumothorax at time of implant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some common conditions for Sinus Tachycardia?

A

Appropriate

  • Fever, thyrotoxicosis, pain etc.
    • Most of time, treat cause of sinus tachycardia

Inappropriate

  • No drivers
  • ?ST
  • ?Automaticity
  • ?Sinus node re-entry
  • Requires drug therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the Clinical significance of Ectopic Beats

How do atrial vs ventricular ectopic beats present in an ECG?

A

Ectopic beats are common, which involves beat of ventricles out of expectation. Majority is benign.

  • Atrial ectopic beats have narrow QRS complex (indicates normal conduction through His-Purkinje system)
  • _Ventricular ectopic beat_s have wide QRS complex (slower conduction)

Symptomatic state proportional to number of factors (prematurity of ectopic, distraction/activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do you assess ectopic beats?

A

Examination for exclusion. Appropriate tests include ECG/echocardiogram/Holter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the Summary of Treatment for Ectopic Beats

A

Summary of Treatment

  1. Assessment and reassurance
  • Make sure ectopy is benign then reassure patients
  • Exclude malignancy by taking thorough history and family history of syncope, sudden cardiac death
  1. Suppressive drug therapy (caution with side effects/adverse drug reactions SE/ADR)
  • Beta blockers, class I agents (?)
  • Drug withdrawal might cause problems
  1. Management of underlying condition
    * Device and surgical/ablation intervention (severe symptoms + focus → ablation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the Class 1 Antiarryhtmic drug therapy

A
  • Na+ channel agents (predominantly blocking)
  • IA = quinidine, procainamide, disopyramide (rapid onset/offset)
    • ↓ Vmax, prolong AP (prolong refractoriness, slow conduction velocity).
    • widens QRS interval, prolongs QT interval
    • may enhance AV conduction, so may be co-prescribed with rate-slow drugs (AV nodal)
  • IB = mexiletine, phenytoin, lidocaine (fast onset/offset)
    • no effect Vmax
    • shorten AP (shorten refractory)
  • IC (most clinical use) = flecainidine, popafenone (slow onset/offset)
    • ↓ Vmax
    • prolong AP
    • no effect on refractoriness, slow conduction velocity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the Class 2 Antiarrthymic drugs

A
  • β-blockers, which block β-adrenergic Rs in SNS
  • = metoprolol, propanolol, , sotalol (low dose = class II activity, high dose = class III activity)
  • cardio-selective (β1) and non-cardio-selective (β1 and β2) properties
  • slows AV node conduction to treat atrial and ventricular arrhythmia
  • can also treat hypertension, post-infarction (reduce mortality rate), HF
  • side effects = bradycardia, fatigue; asthma/wheeze, depressed moods, constipation
  • some patients on chronic β blockade require permanent pacing to manage bradycardia
  • fatigue is a common side effect, but may diminish over time
  • contraindications = asthma, but not chronic obstructive pulmonary disease (COPD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the Class 3 Antiarrthymic drugs (Vaughan Williams Classification)

A
  • K+ channel blocker, can also affect sodium and calcium channels
  • = sotalol, amiodarone, ibutilide.
  • prolongs AP (prolong refractory period, increases rate of repolarization)
  • may slow but not stop VT
  • can affect defibrillation thresholds (variable individual response).
    • Amiodarone ↑ DFTs
    • Sotalol ↓ DFTs
  • prescribed for atrial and ventricular arrhythmia
  • toxicity level can build up cumulatively, therefore monitor patients frequently

Amiodarone can potentiate digoxin → reduce digoxin dose if administering with amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the Class 4 Antiarrthymic drugs (Vaughan Williams Classification)

A
  • slow Ca2+ channel blocker
  • = verapamil, diltiazem
  • affects mainly SA and AV nodes
  • not pro-arrhythmic.
  • side effect of verapamil = ankle swelling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antiarryhtmics can affect…

A

1) Cell membrane
2) Autonomic nervous system
3) Vagal tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antiarrhythmic drugs affect _cell membrane activitie_s by…

A
  • Conduction velocity
  • Length of refractory period
  • Automaticity of SA or AV node
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do Antiarrhythmic drugs affect the ANS?

A
  • It also affect autonomic nervous system (vagal tone):
  • ↑ vagal tone
    • ↓ HR
    • ↓ SA automaticity
    • Slower conduction through the AV node
  • ↓ vagal tone
    • ↑ HR
    • ↑ SA automaticity
    • Faster conduction through the AV node
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the mechanism of pro-arrhythimic effect of Antiarrhythmic drugs

A

Mechanisms are:

  • alterations in re-entry pathways
  • prolonged repolarization
  • development of early after-depolarizations, which cause torsades
    • Torsades de pointes = specific form of polymorphic ventricular tachycardia with a long QT interval
    • characterized by rapid, irregular QRS complexes, appear to be twisting around the ECG baseline
  • increased risk of pro-arrhythmia in heart failure
17
Q

How do you treat long QT intervals?

A
  • acquired long QT due to some drugs given
  • needs recurrent shock treatment
18
Q

Describe what AV nodal re-entrant tachycardia can trigger

How can you treat this?

A
  • due to AV node duality, ectopic trigger
  • “safe” supra-ventricular tachycardia (SVT)
  • medical therapy includes:
    • preventative treatment (β blockers and Ca2+ channel blockers)
    • acutely abort treatment
      • (adenosine- transient AV block)
    • ablation therapy is curative
19
Q

what are the 2 types of AV re-entrant tachycardia?

A
  • ante- vs ortho-dromic tachycardia (via accessory pathway)
  • antedromic travels opposite to normal conduction pathway (wide QRS complex)
  • orthodromic travels same direction as normal conduction pathway (narrow QRS complex)
20
Q

Diagnose

A

Atrial fibrillation

21
Q

Describe the symptoms and treatment of Atrial Fibrillation

A

Symptoms and Treatment

  • Atrial fibrillation is common.
    • There are varying symptoms (many are asymptomatic until complications develop such as stroke, rate related cardiomyopathy)
    • There are morbidity/mortality issues, and co-morbidities.
  • Rate vs rhythm control aims to reduce risk of complications. Control includes drug, device and intervention (?at AV)
    • Note that restoring sinus rhythm hasn’t been proven to reduce risk of stroke
  • Anticoagulation therapy for AF determined by scoring system. Common anticoagulants includes
    • warfarin,
    • heparin (good for short term, not for long term),
    • DOACs .
  • Atrial fibrillatini s not a diagnosis, it is a spectrum of disorders that present as AF.
22
Q

Describe VT/VF

A
  • caused by _reentrant or automatic trigge_r around or in scar tissue
  • VT invades rest of ventricles
  • broad complex due to:
    • activating chamber through cell-cell contact
    • not using normal conduction system (His-Purkinje network)
  • Atria continue to activate and contract independently.
23
Q

How do you manage VT/VF?

A
  • Emergency Management
    • 777
    • Resuscitation
  • Treat Underlying pathology
    • Ischemia,
    • bradycardia,
    • structural disease,
    • metabolic or drug causes
  • ventricular support (anti-ischaemic, ACE inhibitor)
  • antiarrhythmic (β blocker, class III, class I)
  • device (ICD, pacemaker)
  • intervention (surgery – CABG, ablation)
24
Q

Describe the use of Amiodarone

Toxicity

Side Effects

A
  • use to treat VT/VF
  • loading issues and maintenance monitored by thyroid function tests/liver function tests, lung function
  • drug interactions with warfarin and digoxin

Toxicity

  • pulmonary fibrosis
  • hypo- or hyper-thyroidism
  • liver failure
  • renal failure
  • corneal deposits

Side Effects

  • slight blue/red appearance on the face
  • myalgias
  • gait disturbance
  • insomnia
  • prolonged PT (↓ warfarin dosage)
  • Digoxin toxicity (↓ digoxin dosage)
25
Q

Describe the Treatment of Cardiac Rhythm Disturbances

A

Conclusion: Treatment Of Cardiac Rhythm Disturbances

  • Rx for underlying cause (CAD (coronary artery disease)/hypertension/OSA/obesity, scar)
  • Rx of co-morbidities
  • specific tachycardia treatments (drugs/device/intervention)
  • prophylaxis
  • important drug interactions